Innovative Transfusion Medicine, Inc.
FDA inspection history in Florida, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Florida.
Cited most
Across all Innovative Transfusion Medicine observations on file
- 21 CFR 610.47(a)(1)Hepatitis C virus (HCV) “lookback” requirements2
- 21 CFR 606.100(b)Standard operating procedures1
- 21 CFR 606.160(b)Records1
The complete Innovative Transfusion Medicine file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Florida
One Form 483 · 2024 · 4 observations
Latest: Form 483, Oct 7, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-10-07 | 483 Form 483 | Florida | 4 | $99 |
Investigators on these documents
FEI number 3000207042 · most recent document Oct 7, 2024
About Innovative Transfusion Medicine, Inc.
How many FDA Form 483s has Innovative Transfusion Medicine, Inc. received?
FDA Intel has 1 Form 483 on file for Innovative Transfusion Medicine, Inc.; the most recent is dated Oct 7, 2024.
When was Innovative Transfusion Medicine, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Innovative Transfusion Medicine, Inc. is a Form 483 dated Oct 7, 2024, for the site in Florida.
What did FDA cite at Innovative Transfusion Medicine, Inc.?
The regulations cited most in the observations on file for Innovative Transfusion Medicine, Inc. are 21 CFR 610.47(a)(1) (Hepatitis C virus (HCV) “lookback” requirements), 2 times; 21 CFR 606.100(b) (Standard operating procedures), 1 time; 21 CFR 606.160(b) (Records), 1 time.